Slide 1: 1st Quarter Fiscal 2026 Earnings Presentation
1st Quarter Fiscal 2026 Earnings Presentation November 6, 2025 | We shop. You save.
Slide 2: Disclaimer
Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use o
Slide 3: 1Q Earnings Highlights
1Q Earnings Highlights • Consolidated ◦ Strong revenue growth of 13% year-over-year, driven by Healthcare Services ◦ Adjusted EBITDA* of $(32) million, compared to $(25) to $(30) million guided range provided on 4Q fiscal 2025 earnings call ◦ Year-over-year EBITDA decline driven by new SEP dynamics
Slide 4: Well Prepared to Benefit from Another Dynamic AEP
Well Prepared to Benefit from Another Dynamic AEP Market Backdrop Continued Disruption Policy Terminations Growth Areas Elevated beneficiary disruption as Plan terms and benefit curtailment Growth focus areas include HMOs, carriers continue to prioritize MA elevated again this year SNPs and Geo-spec
Slide 5: SelectRx Adds Clinical Value and Improves Health Outcomes
SelectRx Adds Clinical Value and Improves Health Outcomes Improved Medicare Advantage Improved Medication Reduced Retention Adherence1 Hospitalizations2 5 - 15% ~10% ~20% Improvement in 90-day MA active Increase in adherence based on Reduction in inpatient hospital rates when active on SelectRx Adhe
Slide 6: Consolidated Financial Summary
Consolidated Financial Summary Commentary Revenue Adjusted EBITDA* $MM $MM • Double-digit revenue growth $329 driven by continued strength in Healthcare Services $292 • Original forecast of $(25) – (30) million in Adjusted EBITDA* • New SEP eligibility guidelines complicate year-over-year $(2) compa
Slide 7: Senior Financial Summary
Senior Financial Summary Commentary Revenue Adjusted EBITDA $MM $MM $93 • SEP eligibility impacts to close rates and policy volume $59 $8 • Strong tenured agent retention and tenure mix • >300% increase in new agent hires year-over-year to support $(21) AEP and OEP seasons 1Q25 1Q26 1Q25 1Q26 | We s
Slide 8: Healthcare Services KPIs
Healthcare Services KPIs SELECTRX Members Revenue & Adjusted EBITDA 120 $MM 108 107 106 100 97 87 $214 $221 80 $183 $190 $156 60 1Q25 2Q25 3Q25 4Q25 1Q26 40 20 $12 $6 $7 $5 $2 0 1Q25 2Q25 3Q25 4Q25 1Q26 REVENUE ADJUSTED EBITDA | We shop. You save. 8
Slide 9: Life Financial Summary
Life Financial Summary Commentary Revenue Adjusted EBITDA $MM $MM $47 • Strong operational quarter for Term Life $39 • Shifted Senior agents to Life division during a slower SEP period $6 $6 • Business continues to be a source of consistent, sustainable profit and cash flow 1Q25 1Q26 1Q25 1Q26 | We
Slide 10: Supplemental Information
Supplemental Information | We shop. You save. 10
Slide 11: Adjusted EBITDA to Loss before income tax reconciliation by Segment (1Q FY2026)
Adjusted EBITDA to Loss before income tax expense (benefit) Reconciliation by Segment 1Q FY 2026 Healthcare (in thousands) Senior Services Life Total Total revenue from reportable segments $ 58,996 $ 221,351 $ 46,647 $ 326,994 Less: Cost of commissions and other services revenue (41,897) (6,301) (17
Slide 12: Adjusted EBITDA to Loss before income tax reconciliation by Segment (1Q FY2025)
Adjusted EBITDA to Loss before income tax expense (benefit) Reconciliation by Segment 1Q FY 2025 Healthcare (in thousands) Senior Services Life Total Total revenue from reportable segments $ 92,908 $ 155,739 $ 39,290 $ 287,937 Less: Cost of commissions and other services revenue (41,127) (5,879) (14
Slide 13: Reconciliation of Net loss to Adjusted EBITDA
Reconciliation of Non-GAAP Measure Reconciliation of Net loss to Adjusted EBITDA 1Q FY (in thousands) 2026 2025 Net loss $ (30,459) $ (44,546) Share-based compensation expense 4,327 3,846 Transaction costs 185 826 Depreciation and amortization 4,300 5,599 Loss on disposal of property, equipment, and
Slide 14: SelectQuote Inc. Contact and Investor Relations
SelectQuote Inc. 6800 West 115th Street Suite 2511 Overland Park, Kansas 66211 Phone: (877) 678-4086 Investor Relations investorrelations@selectquote.com | We shop. You save. 14